# Xytis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xytis

- Industry: Biotechnology
- Headquarters: Irvine, US
- Website: www.xytis.com
- Total disclosed funding: $32M
- Latest round: Series B (Apr 7, 2008)
- Investors on record: 4

## About

Xytis specializes in domain name registration, offering a platform for the acquisition of premium domain names. Its services aim to enhance online presence for businesses and individuals across the globe.Founded in 2004 in Irvine, US, Xytis operates in the domain registration sector, focusing on premium domain names. The company has undergone significant developments, including a successful Series B funding round in April 2008, raising USD 7.5 mn from investors such as Atlas Venture, CDC Enterprises, and Sanderling Ventures, bringing the total amount raised to USD 7.5 mn. The founder has a notable history, though specific details on prior ventures are not available.Xytis.com provides domain name registration services, focusing on premium domain names. Customers can purchase domains outright or through structured payment plans, enhancing their online identity. The platform serves a diverse range of clients including entrepreneurs and established corporations, and its services are marketed globally, particularly in North America, Europe, and Asia.Xytis.com generates revenue primarily from direct sales of domain names. Its pricing model includes a fixed purchase price or an installment plan, facilitating manageable acquisition for customers. Premium domain names are priced at USD 2,995 with a 24-month payment plan available at USD 124.79 per month, ensuring a consistent revenue stream as customers fulfill their payment commitments.Xytis plans to leverage its recent Series B funding to enhance its product offerings and expand into new geographic markets. The 2008 funding round will support initiatives aimed at introducing additional services tailored to customer needs. The company is exploring growth opportunities in emerging markets within Asia and Europe, aiming to broaden its customer base by the end of 2009.

## Funding rounds

- Series B, Apr 7, 2008, $7.5M — Atlas Venture, Sanderling Ventures, CDC Enterprises
- Series B, Jan 9, 2006, $25M — Atlas Venture, Sanderling Ventures, Ventech, CDC Enterprises

## Investors

- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Series B
- Sanderling Ventures (https://capitalatlas.ai/funds/sanderling-ventures) — Series B
- Ventech (https://capitalatlas.ai/funds/ventech) — Series B
- CDC Enterprises (https://capitalatlas.ai/funds/cdc-enterprises) — Series B